Would you consider local therapy (e.g. XRT) in patients with mRCC with oligometastatic disease progression?

This is a good question. The role of local therapy in mRCC should (in my opinion) be limited to 2 settings.

a) A patient with mRCC who is experiencing pain from a metastatic site.

b) A patient with an indolent disease course and overall low volume of metastatic disease in whom local therapy such as...